Navigation Links
Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
Date:5/14/2008

Conference Call To Be Held Thursday, May 15, 2008 at 9:00 a.m. Eastern Time

HOPKINTON, Mass., May 14 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today reports operational and financial results for the quarter ended March 31, 2008 and provides further information for fiscal year 2008. Recent highlights include:
- Encouraging 12 month interim results from the Phase I/IIa Cethrin(R)

clinical trial in acute spinal cord injury

- Entry into an option agreement which provides the Company with an

option to amend its Cethrin license to lower milestone payments and

royalty rates in exchange for a fee

- Expansion of sites for the first stage of the Parkinson's or Essential

Tremor, or POET-2, Altropane(R) Phase III clinical trial program

- $5 million raised in March 2008

"Our programs continue to show promising progress," said Peter G. Savas, Chairman and Chief Executive Officer of Alseres. "We are encouraged by the unprecedented sensory and motor recovery seen in patients treated with Cethrin in our Phase I/IIa clinical trial. Key opinion leaders with whom we have spoken are highly impressed by the efficacy findings in the study. Armed with these results and after discussions with regulatory authorities and expert advisors, we were able to reduce the planned size of our Phase IIb clinical trial from 200 patients to a maximum of 100 patients providing us with potential time savings and cost reductions."

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO)

"We plan to start this trial in acute cervical spinal cord injury patients in the seco
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
2. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
3. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
4. Alseres Pharmaceuticals, Inc. Raises $5 Million
5. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
6. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
7. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
8. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
9. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
10. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
11. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dennis Thompson HealthDay ... Researchers could be closing in on a "fountain of youth" ... the health of older adults, a new study suggests. ... given a drug that targets a genetic signaling pathway linked ... Novartis report. The experimental medication, a version ...
(Date:12/25/2014)... Newton, North Carolina (PRWEB) December 25, 2014 ... a North Carolina Retirement Community, recently showed their ... and girls of the Catawba County Parenting Network- ... meal, the 10 children gathered around the largest ... community to open presents purchased by residents of ...
(Date:12/24/2014)... December 25, 2014 Epigenetics finds applications ... research, including oncology, drug discovery, developmental biology, and research ... as one of the most widely used techniques for ... GLOBOCAN, the prevalence of cancer is rapidly growing worldwide. ... 8.2 million cancer deaths, and 32.6 million people living ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial ... and med-spa with the addition of new Silk Peel ... treatments and services. , “Silk Peel is a procedure ... Ho. “As a result it can address issues like ... discolorations or blemishes.” , Similar to microdermabrasion, Silk ...
(Date:12/24/2014)... Mike Billings , PT, MS, ... Derek Fenwick, PT, MBA, GCS, Director of Professional Development ... the passing of the Improving Medicare Post-Acute Care ... taping of the Infinicast, the two leaders discuss how ... Security Act to standardize post-acute assessment data for quality, ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2
... , CAMARILLO, Calif., Sept. 9 ... Science Foundation (NSF) recently honored Dr. Blake Gillespie, Assistant Professor ... (CAREER) award. , , The award, ... research in protein-ligand interactions and biomolecular dynamics, is supported by ...
... Imaging technology might advance treatment of psychotic disorders, researchers ... technology has helped researchers pinpoint the part of the ... as schizophrenia begin, a new study says. , The ... in their early stages and help scientists develop more ...
... WASHINGTON, Sept. 9 Statement of Lisa A. ... on reports from White House press secretary Robert Gibbs that ... to Congress: , , (Logo: ... are encouraged that President Obama understands the tremendous burden that ...
... KALAMAZOO, Mich., Sept. 9 Stryker Corporation (NYSE: ... call on Tuesday, October 20, 2009, at 4:30 p.m., Eastern Time, ... 30, 2009, and provide an operational update. Operating results for the ... that day. , , To participate in the ...
... , , , ... Vermont and Chair of the National Governors Association will speak at a ... yearlong NGA initiative, Rx for Health Reform: Affordable, Accessible, ... the success of national health care reform. , , ...
... , GORDONSVILLE, Va., Sept. 9 PBM ... Beginnings(R) NeoCare(TM) Weight Gain Infant Formula. Comparable to Similac(R) NeoSure(R), ... meet the nutritional needs of low birth weight infants (LBW) ... suggests that catch-up growth increases when feeding infants nutrient-enriched formulas ...
Cached Medicine News:Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:Brain Scans Could Help Spot Schizophrenia Earlier 2Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2Health News:Stryker To Host Conference Call on October 20, 2009 2Health News:NGA Chair, Vermont Governor Douglas to Speak on States' Role in Health Care Reform at the National Press Club on September 17 2Health News:Bright Beginnings(R) NeoCare(TM) Value-Priced Weight Gain Infant Formula Now Available Online at www.pbmstore.com 2
(Date:12/24/2014)... , Dec. 24, 2014  The International Trade Commission ... ResMed (RMD) against BMC Medical. In a notice issued on ... found that ResMed,s patent on its humidifier was invalid. ... a "monumental win". "We are very excited with the ITC,s ... position that we have taken since the very beginning on ...
(Date:12/24/2014)... Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... is proud to announce Jennifer Hagerman , Pharm.D., ... will take office as the president of the Michigan ... ceremony will take place Feb. 28, 2015, at the ... at the Renaissance Center in Detroit, Michigan ...
(Date:12/24/2014)... , December 24, 2014 ... at an average rate of 8.1%. The US has ... knee and spine surgeries are the common orthopedic procedures ... have a lower penetration. Increased number of product recalls ... Non-metallic orthopedic devices have gained popularity in the industry ...
Breaking Medicine Technology:ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... CHAPEL HILL, N.C. , July 23 The ... continues to evolve as new medicines and technologies create valuable market ... new oncology products are scrutinizing their strategies and tactics to support ... , ...
... , July 23 Sales executives agree that delivering ... Yet only 6 percent of district sales managers currently understand and ... , , ... of health outcomes, evidence based medicine and reimbursement," states an interviewed ...
Cached Medicine Technology:Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches 2Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches 3Health Outcomes Data Essential to Biopharmaceutical Sales Process 2Health Outcomes Data Essential to Biopharmaceutical Sales Process 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: